These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 10981526)

  • 21. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of interleukin-12 and interleukin-15 on CD69 expression of T-lymphocytes and natural killer cells from umbilical cord blood.
    Lin SJ; Chao HC; Kuo ML
    Biol Neonate; 2000 Oct; 78(3):181-5. PubMed ID: 11044766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
    Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
    Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
    Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T
    Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
    Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
    Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.
    Decot V; Voillard L; Latger-Cannard V; Aissi-Rothé L; Perrier P; Stoltz JF; Bensoussan D
    Exp Hematol; 2010 May; 38(5):351-62. PubMed ID: 20172016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
    Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
    Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of CD16zeta in NK cells of B-cell non-Hodgkin's lymphoma patients and in vitro killing effect of rituximab combined lymphokine-activated killer cells on B-NHL cells].
    Shi YX; Zhang XS; Xia JC; Li YQ; Xu RH; Han WJ; Zhang JH; Guan ZZ; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):837-42. PubMed ID: 17697543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
    Boissel L; Tuncer HH; Betancur M; Wolfberg A; Klingemann H
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors.
    Lovgren TR; Tarantolo SR; Evans C; Kuszynski CA; Joshi SS
    In Vivo; 2002; 16(6):541-50. PubMed ID: 12494899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of influenza A infection on umbilical cord blood natural killer function regulation with interleukin-15.
    Lin SJ; Cheng PJ; Lin TY; Lee PT; Hsiao HS; Kuo ML
    J Infect Dis; 2012 Mar; 205(5):745-56. PubMed ID: 22262794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood.
    Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2003 May; 88(5):561-9. PubMed ID: 12745276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15.
    Haraguchi K; Suzuki T; Koyama N; Kumano K; Nakahara F; Matsumoto A; Yokoyama Y; Sakata-Yanagimoto M; Masuda S; Takahashi T; Kamijo A; Takahashi K; Takanashi M; Okuyama Y; Yasutomo K; Sakano S; Yagita H; Kurokawa M; Ogawa S; Chiba S
    J Immunol; 2009 May; 182(10):6168-78. PubMed ID: 19414770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
    Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U
    J Immunother; 2010; 33(2):200-10. PubMed ID: 20145545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential cyclosporin-A sensitivity on survival and activation of umbilical cord and adult peripheral blood CD4+ T cells.
    Lin SJ; Kuo ML; Cheng PJ; Hsiao SS
    Transpl Immunol; 2007 Nov; 18(2):172-8. PubMed ID: 18005864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
    Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
    Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.